Story perspectives

Captagon Production Plummets in Syria Amid Crackdown

12/23/2025

Summary

Story summary

Captagon production in Syria declined after the fall of Bashar al-Assad in December 2024.
The United Nations Office on Drugs and Crime (UNODC) reported 15 large laboratories and 13 smaller warehouses were shut.
Regional countries coordinate to curb drug smuggling, with record seizures in 2025.
Syrian authorities have intercepted over 177 million Captagon tablets since December 2024.
The UNODC warns disruption could push traffickers toward methamphetamine and requires regional action.

History

Historical Context

The Syrian Civil War, ignited in 2011 by protests against Bashar al-Assad's regime, has led to widespread instability and a surge in drug production, particularly Captagon. By 2025, the UNODC reported the closure of 28 drug facilities, reflecting ongoing challenges in drug trafficking and the need for regional cooperation to combat narcotics, as over 177 million tablets were intercepted.

1 of 2

Story summary

Captagon production in Syria declined after the fall of Bashar al-Assad in December 2024.
The United Nations Office on Drugs and Crime (UNODC) reported 15 large laboratories and 13 smaller warehouses were shut.
Regional countries coordinate to curb drug smuggling, with record seizures in 2025.
Syrian authorities have intercepted over 177 million Captagon tablets since December 2024.
The UNODC warns disruption could push traffickers toward methamphetamine and requires regional action.

1 / 2